Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21166545 | 0.87 | TAS1R3 (0.35) | CYP2D6ALDH1A1ADRA2AADRA1AKDM4E | |
| SCHEMBL16133969 | 0.82 | CYP2D6 (0.41) | CYP2D6ALDH1A1ADRA2AADRA1AKDM4E | |
| SCHEMBL17522202 | 0.76 | CALM1 (0.40) | ALDH1A1ADRA2AADRA1AKDM4EMEN1 | |
| SCHEMBL19243000 | 0.76 | ALDH1A1 (0.40) | ALDH1A1LMNAGAAMAPT | |
| SCHEMBL14450148 | 0.76 | TUBB4A (0.37) | CYP2D6ADRA2AADRA1AMEN1KMT2A | |
| SCHEMBL19801119 | 0.75 | TAAR1 (0.34) | — | |
| SCHEMBL12606793 | 0.75 | CA12 (0.50) | CYP2D6ALDH1A1ADRA2AADRA1AADRB2 | |
| SCHEMBL11437277 | 0.75 | CA12 (0.50) | CYP2D6ALDH1A1ADRA2AADRA1AADRB2 | |
| SCHEMBL10172021 | 0.75 | CA12 (0.50) | CYP2D6ALDH1A1ADRA2AADRA1AADRB2 | |
| SCHEMBL11251015 | 0.75 | CYP2D6 (0.59) | CYP2D6ADRA2AADRA1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190218220-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218220-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | PRKACA, PRKDC, AURKC | CYP2D6 3307/4885ALDH1A1 3719/4885ADRA2A 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.